SCHEMBL16800423

SCHEMBL16800423

Cn1cc(NC(=O)OCc2ccccc2)c(CO)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.52
MGLL Q99685 2/20 0.48
FAAH O00519 1/20 0.48
POLB P06746 1/20 0.48
PTGDR2 Q9Y5Y4 2/20 0.44
TACR3 P29371 1/20 0.44
CSNK1D P48730 1/20 0.44
MAOB P27338 1/20 0.44
CASP3 P42574 1/20 0.43
KMT2A Q03164 1/20 0.43
KAT2B Q92831 1/20 0.43
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
TSHR P16473 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21964564 0.87 NPC1 (0.51) NPC1RAB9ASMN1; SMN2MGLLFAAH
SCHEMBL16797992 0.84 NPC1 (0.53) NPC1RAB9ASMN1; SMN2MGLLFAAH
SCHEMBL18300903 0.76 ATM (0.41) NPC1RAB9ASMN1; SMN2POLBALDH1A1
SCHEMBL27457954 0.75 GSK3B (0.40) PTGDR2
SCHEMBL5578485 0.74 NPC1 (0.41) NPC1RAB9ASMN1; SMN2MGLLFAAH
SCHEMBL15516309 0.73 NPC1 (0.66) NPC1RAB9ASMN1; SMN2MGLLPOLB
SCHEMBL21960979 0.72 NPC1 (0.46) NPC1RAB9ASMN1; SMN2MGLLFAAH
SCHEMBL31422519 0.72 NPC1 (0.50) NPC1RAB9ASMN1; SMN2MGLLPOLB
SCHEMBL10874779 0.72 NPC1 (0.68) NPC1RAB9ASMN1; SMN2POLBKMT2A
SCHEMBL5853278 0.71 NPC1 (1.00) NPC1RAB9ASMN1; SMN2MGLLPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015082411-A1 ARYL- AND HETARYL-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE-3-CARBOXAMIDES AND USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2015-06-11 WO disclosed